We Help You Scale Faster and More Efficiently
We have expertise in strengthening companies across enterprise technology and healthcare in North America and focus on building industry leaders. Providing capital is just one part of the value add we bring. We partner closely with the teams in which we invest to help build enterprises that matter.
We have been partnering with remarkable management teams to help them achieve their greatest potential for 15+ years. Our model is to work side-by-side with teams to get ahead of scaling challenges and optimize for the best possible outcome for all parties.
We Invest Behind Visionary Entrepreneurs
With Big Ideas
Virtual care network for maternity health
Early in the digital health revolution, Kate Ryder recognized the need for a more equitable approach to healthcare across the women’s and family health continuum. Too many people suffered from a lack of access to quality care when they needed it during their family journey, which resulted in the United States having both the highest cost of care and the worst outcomes among OECD countries.
SMC shared Kate’s vision for a virtual care platform that could meet the multitude of needs people have as they grow their families. Since leading the company’s Series A round in 2017, the firm has had a front-row seat to Maven’s explosive growth. Today, Maven serves patients in more than 100 countries through its partnerships with leading global employers and payers, offering an ever-expanding suite of products that include support for those going through preconception, fertility, adoption, surrogacy, parenting, and menopause journeys. In 2021, Maven became the first company dedicated to women’s and family health to be valued at more than $1 billion.
Governance, risk, and compliance for enterprise collaboration platforms
Jeff saw the emergence of workplace chat platforms in the years leading up to the COVID-19 pandemic. After offices shut down across the country, usage of Slack, Microsoft Teams, and Zoom exploded as companies quickly adapted to conversational chat platforms as a middle ground between email and in person communication. Just like with email, companies have started to realize the need to secure collaboration data and to leverage it to better understand the voice of the employee.
Revolutionizing clinical trials via digital biomarkers and remote monitoring
While at Merck, Chris Benko understood that the clinical trial space lacked the data they needed to properly understand the efficacy of various therapeutics, particularly those serving CNS (Central Nervous System) disease states.
He set out to build a business around the emerging use of third party devices to track digital biomarkers, or so-called digital endpoints which would then be analyzed through proprietary algorithms. We share Chris’ vision that this data set is easier to collect, opens up many more patients for clinical trials and is now an objective measurement of success (vs. traditional subjective means).
Partnering with World Class Management Teams
"As a first-time founder, having the right partner to help us think through the host of strategic decisions we needed to make was critical. SMC provided support along all points of the business-building journey and ultimately added tremendous value to the organization."
Debra Geihsler, Co-founder
"We've only been partners for a short time, but SMC has helped add a very talented new board member, a consultant with tremendous relevant experience, and has introduced us to high-level pipeline opportunities, some of which have become important customers."
Greg Dolan, CEO
Keen Decision Systems
"Among many other incredibly helpful strategic and operational insights, SMC has financed a transformative add-on acquisition for the company, introduced us to our new debt financing partner and worked closely with us on multiple budgeting and planning exercises. I would be honored to partner with SMC again on a future venture."
Andrei Zimiles, CEO
Genomenon Takes a Leap in the Race to Curate the Genome
Genomenon Inc., a leading genomic intelligence company, today announced the first milestone in its journey to curate the human genome with the release of Mastermind 3.0, now including the clinical exome fully curated at the gene level.
ShowdMe raises Series A Financing led by Spring Mountain Capital and Blue Heron Capital
ShowdMe, the premier compliance training partner for home care agencies and skilled nursing facilities, announces today a Series A investment led by Spring Mountain Capital and Blue Heron Capital.